Related Experiment Videos
Diversity of molecular phenotypes in acute leukemias
S Mizutani1, K Nakamura, M Ozaki
1National Children's Medical Research Center, Tokyo, Japan.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Dependence of serum erythropoietin level on erythropoiesis in leukemia.
Haematology and blood transfusion·1990
Complications of bone marrow transplantation in Chinese.
Haematology and blood transfusion·1990
High-dose chemotherapy with noncryopreserved autologous bone marrow transplantation for acute myeloid leukemia in first complete remission.
Haematology and blood transfusion·1990
Heterogeneity in protein patterns of CGL blast crisis cells: discrimination between lymphatic and myeloic lineages.
Haematology and blood transfusion·1990
Global research landscape of vascular access device-related complications in oncology: A bibliometric analysis.
The journal of vascular access·2026
Surgical Outcomes and Histopathological Risk Factors in Periocular Basal Cell Carcinoma: A Single-Centre Study of 100 Patients.
Turkish journal of ophthalmology·2026
Nationwide Survey of Association Between Fever and Epileptic Seizure in CDKL5 Deficiency Disorder Revealed Therapeutic Implications.
Annals of clinical and translational neurology·2026
Deep Generative Model of Macrophage Immune Response for Hepato-intestinal Tumor Therapy Optimization.
Cyborg and bionic systems (Washington, D.C.)·2026